Transposition mechanism of IS<i>Apl1</i>-the determinant of colistin resistance dissemination.

Authors:
Li W; He Z; Di W; Xu W; Li Y and 1 more

Journal:
Antimicrob Agents Chemother

Publication Year: 2024

DOI:
10.1128/aac.01231-23

PMCID:
PMC10916398

PMID:
38289082

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Antimicrob Agents Chemother

Abbreviation: Antimicrob Agents Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of <i>Clost…
Bassères E; Eubank TA; Begum K and 6 more (2024) - Transparency Score: 3/6
Clofazimine as a substitute for rifampicin improves efficacy of <i>Mycobacterium avium</i> pulmonar…
Salillas S; Raaijmakers J; Aarnoutse RE and 8 more (2024) - Transparency Score: 3/6
Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
Hilliard JJ; Jakielaszek C; Mannino F and 10 more (2024) - Transparency Score: 3/6
Inhibition of <i>Pseudomonas aeruginosa</i> quorum sensing by chemical induction of the MexEF-oprN …
Kristensen R; Andersen JB; Rybtke M and 9 more (2024) - Transparency Score: 3/6
Limitations of antifungal prophylaxis in preventing invasive <i>Candida</i> surgical site infection…
Carugati M; Arif S; Yarrington ME and 8 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare no conflict of interest."

Evidence found in paper:

"This study was supported by the Fundamental Research Funds for the Central Universities (YD9100002013), the National Key Research and Development Program of China (2021YFC2300300), and the National Natural Science Foundation of China (32070132 and 31870126). Conceptualization: W.L., Y.L., and B.S.; Data curation: W.L., W.X., Y.L., and B.S.; Formal analysis: W.L. and Z.H.; Funding acquisition: Y.L. and B.S.; Investigation: W.L. and Z.H.; Methodology: W.L., W.D., and Z.H.; Project administration: Y.L. and B.S.; Resources: Y.L. and B.S.; Supervision: Y.L. and B.S.; Validation: W.L. and B.S.; Visualization: W.L. and B.S.; Writing—original draft: W.L.; Writing—review & editing: W.L., Y.L., and B.S."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025